Read + Share
Amedeo Smart
Independent Medical Education
Rosenstengle C, Serper M, Asrani SK, Bittermann T, et al. Variation in intention-to-treat survival by MELD subtypes: All models created for end-stage liver disease are not equal. J Hepatol 2025;82:268-276.PMID: 39181212
Email
LinkedIn
Privacy Policy